Skip to main content
Premium Trial:

Request an Annual Quote

Eli Mintz


Compugen of Tel Aviv, Israel, has named co-founder Eli Mintz as chairman of the company’s wholly owned US subsidiary, which is headquartered in Jamesburg, NJ.

Since founding the bioinformatics company in 1993, Mintz has served as its CEO and president of its US subsidiary. Mintz will continue to serve on the parent company’s board of directors and will devote about forty percent of his time to the new chairman position.

With this change in position, Mintz will no longer be involved with the company on a full-time basis.

Mintz’ other experience includes a stint as marketing director of Orckit Communications in Israel, and eight years in the Israeli Defense Forces’ Talpiot Program. Mintz holds a Bachelor of Science degree in physics, mathematics, and computer science from The Hebrew University, Jerusalem, and an MBA from INSEAD, France.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.